Seroba’s portfolio company, Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics (targeted alpha ther... Read more

Dublin, Ireland. 30 January 2019. Seroba portfolio company, Labcyte, has been acquired by Beckman Coulter Life Scienc... Read more

PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease. Funds Will Support Pivot... Read more

Seroba portfolio company, Atlantic Therapeutics, has raised €28 million following FDA approval for its INNOVO® therapy device to tre... Read more

TOP